Release Date: 17/10/22 08:34 Summary: Leadership Transition and Trading Update Price Sensitive: Yes Download Document 266.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%